Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response-Reference-Cited by-同舟云学术

Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response

Published:2006-10 Issue:4 Volume:176 Page:1349-1353
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

van der Heijden Antoine G.¹,Moonen Paula M.J.¹,Cornel Erik B.²,Vergunst Henk³,de Reijke Theo M.⁴,van Boven Erika⁵,Barten Evert J.⁶,Puri Rajiv⁷,van Kalken Coenraad K.⁸,Witjes J. Alfred¹

Affiliation:

1. University Medical Centre Nijmegen, Nijmegen, The Netherlands

2. Twente Hospital Group Location SMT, Hengelo, The Netherlands

3. Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands

4. Academic Medical Centre, Amsterdam, The Netherlands

5. Maasziekenhuis, Boxmeer, The Netherlands

6. Ziekenhuis Velp, Velp, The Netherlands

7. Bradford Hospital National Health Service Trust, Bradford, United Kingdom

8. NDDO Research Foundation, Amsterdam, The Netherlands

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Cancer Incidence in Five Continents;Parkin,2003

2. Cancer statistics, 2005;Jemal;CA Cancer J Clin,2005

3. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer;Sylvester;J Urol,2002

4. The role of NAD(P)H;Walton;Cancer Commun,1991

5. Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder;van der Heijden;J Urol,2005

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel intravesical therapeutics in the treatment of non-muscle invasive bladder cancer: Horizon scanning;Frontiers in Surgery;2022-07-26

2. Synthetic DNA‐Targeted Chemotherapeutic Agents And Related Tumor‐Activated Prodrugs;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

3. Chemoablation in Urothelial Carcinoma: A Systematic Review and Future Perspectives;Urology;2020-10

4. Apaziquone for Nonmuscle Invasive Bladder Cancer;Urologic Clinics of North America;2020-02

5. Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non–muscle-invasive Bladder Cancer;European Urology Oncology;2019-09